title: Medicines regulation and health technology assessment.
abstract: Health technology assessment (HTA) is as important as regulation to allow patients access to new medicines, and there are demands that the two processes should be carried out more closely together in time. Although the methods used by the regulator differ from those used by the health technology assessor, there is scope for synergies that would be useful to both parties. By providing scientific advice to sponsors of new medicines, both regulators and health technology assessors can also provide support for drug innovation.
authors.affiliation: Medicines and Healthcare Products Regulatory Agency, London, UK. Alasdair.Breckenridge@mhra.gsi.gov.uk
authors.forename: A
authors.initials: A
authors.lastname: Breckenridge
authors.forename: K
authors.initials: K
authors.lastname: Woods
authors.forename: T
authors.initials: T
authors.lastname: Walley
mesh_terms: D017277:Drug Approval; D015195:Drug Design; D004345:Drug Industry / Q000331:legislation & jurisprudence* / Q000458:organization & administration; D049673:History, 20th Century; D006801:Humans; D007880:Legislation, Drug / Q000266:history; D004364:Pharmaceutical Preparations / Q000600:supply & distribution; D013673:Technology Assessment, Biomedical / Q000379:methods*
chemical_list: D004364:Pharmaceutical Preparations